Skip to content

Online Cognitive Behavioural Therapy for Addiction: Efficacy and Cost-Effectiveness in a Pragmatic Clinical Trial

Online Cognitive Behavioural Therapy for Addiction: Efficacy and Cost-Effectiveness in a Pragmatic Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03767907
Enrollment
49
Registered
2018-12-07
Start date
2018-10-01
Completion date
2021-12-31
Last updated
2022-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Dependence

Keywords

cognitive behavioural therapy, online treatment

Brief summary

The purpose of this study is to compare the efficacy and cost-effectiveness of a Computer-based Training for Cognitive Behavioural Therapy (CBT4CBT) to treatment as usual in outpatients seeking treatment for substance use disorder.

Detailed description

Fifty-two adult outpatients seeking treatment for substance use disorder from the Centre for Addiction and Mental Health Addictions Program will be randomized to receive either a computer-based training for cognitive behavioural therapy or treatment as usual for eight weeks. Participants will complete interviews, questionnaires, and other assessments (urine toxicology and physiological assessments) at week 0, at week 8, and at 6 month follow-up). Measures will assess alcohol and drug consumption, substance use disorder symptoms and associated features, quality of life, and healthcare costs.

Interventions

BEHAVIORALComputer-based Training for Cognitive Behavioural Therapy

Interactive content organized into seven modules, illustrating real-life scenarios associated with common risky situations, which illustrate the application of targeted skills and strategies

BEHAVIORALTreatment As Usual

Treatment as usual will include standard psychosocial care determined to be appropriate or necessary, on an individual patient basis.

Sponsors

Centre for Addiction and Mental Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. 18 years of age or older 2. Fluency in English 3. Understanding and willingness to comply with study requirements 4. Meet diagnostic criteria for current substance use disorder 5. Have used substance in the past 30 days 6. Treatment-seeking for substance misuse

Exclusion criteria

1. Unable to read at sixth grade level 2. Untreated or unstable severe psychiatric or medical disorder 3. Acute suicidal or homicidal ideation

Design outcomes

Primary

MeasureTime frameDescription
Timeline Follow-Back (TLFB)30 daysFrequency (days) of substance use over the past 30 days

Secondary

MeasureTime frameDescription
Urine Toxicology Screen30 daysDetermine substance use in past 30 days
Addiction Severity Index (ASI)30 daysSubstance Use Disorder symptom severity Subscale scores are calculated for 7 domains (medical, employment/support status, alcohol, drug, legal, family/social and psychological). Subscale scores are summed scores ranging from 0-1 with higher scores indicating greater problem severity.
WHO Quality of Life (WHOQOL-BREF)4 weeksQuality of Life Subscale scores are calculated for 4 domains (physical health, psychological, social relationships and environment) and for overall and general health quality of life. Subscale scores have a range of 0 to 100 with higher scores indicating greater quality of life.
Program and Client Costs-Substance Abuse Treatment (PACC-SAT)7 daysHealthcare Costs

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026